SCHEMBL4429301

SCHEMBL4429301

NC(=O)CNC(=O)c1ccc(OCc2ccccc2)cc1F

nearest known ligand 0.63

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SPHK2 Q9NRA0 3/20 0.63
PARP10 Q53GL7 2/20 0.54
PARP15 Q460N3 1/20 0.54
NOX1 Q9Y5S8 1/20 0.53
SPHK1 Q9NYA1 1/20 0.53
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 1/20 0.51
MAOB P27338 5/20 0.50
MAOA P21397 1/20 0.48
CTSV O60911 1/20 0.47
CTSL P07711 1/20 0.47
PARP14 Q460N5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505966 0.90 MAOB (0.63) SPHK2PARP10PARP15SPHK1MAOB
SCHEMBL3506405 0.90 MAOB (0.65) SPHK2PARP10PARP15MAOBMAOA
SCHEMBL4428735 0.84 PARP15 (0.45) SPHK2PARP10PARP15MAOBMAOA
SCHEMBL4426077 0.82 MEN1 (0.58) SPHK2NOX1SPHK1MEN1NPC1
SCHEMBL4432758 0.82 ALDH1A1 (0.58) PARP10PARP15NOX1MEN1NPC1
SCHEMBL2997270 0.81 MAOB (0.62) PARP10PARP15NOX1MEN1KMT2A
Hydrochloric Acid SCHEMBL9015457 0.80 MAOB (0.61) PARP10PARP15NOX1MEN1KMT2A
SCHEMBL27683488 0.80 MAOB (0.61) PARP10PARP15NOX1MEN1KMT2A
SCHEMBL5808180 0.79 MAOB (0.60) SPHK2PARP10PARP15MEN1NPC1
SCHEMBL5806883 0.78 MAOB (0.63) PARP10PARP15MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951884-B2 Fluorobenzamides and uses thereof HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US claimed
US-20030236304-A1 Fluorobenzamides and uses thereof F. HOFFMANN-LA ROCHE AG (CH) 2003-12-25 US claimed
EP-1515926-B1 FLUOROBENZAMIDES SUITABLE FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR SENILE DEMENTIA HOFFMANN LA ROCHE (CH) 2009-04-08 EP disclosed
CN-1274669-C Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia HOFFMANN LA ROCHE (CH) 2006-09-13 CN disclosed
US-6951884-B2 Fluorobenzamides and uses thereof HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
CN-1659135-A Fluorobenzamides suitable for the treatment of alzheimer's disease or senile dementia HOFFMANN LA ROCHE (CH) 2005-08-24 CN disclosed
US-20030236304-A1 Fluorobenzamides and uses thereof F. HOFFMANN-LA ROCHE AG (CH) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236304-A1 Fluorobenzamides and uses thereof MAOB, MAOA, BCHE SPHK2 2586/4885PARP10 1686/4885PARP15 806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.